![](https://geneonline.news/en/wp-content/uploads/2020/08/IPO-348x215.jpg)
CureVac Shares Catapult 494% Following Successful IPO Debut
The Tübingen-based biotech firm which is one of the eight big startups in Europe in terms of funding, went public last week at $16 per common share and has been …
Read MoreThe Next Generation Biotech Media
The Tübingen-based biotech firm which is one of the eight big startups in Europe in terms of funding, went public last week at $16 per common share and has been …
Read MoreVaccine development is traditionally a slow process, due to the rigorous preclinical testing, lead optimization, and subsequent clinical trials performed on healthy volunteers and patients. Hence the announcement of Russia’s …
Read MoreAscletis’ First Dual-DAA Regimen for HCV Bags China Approval On July 31, 2020, Ascletis Pharma Inc. in China announced that its dual-drug, all-oral HCV treatment had got the marketing approval …
Read MoreOn August 4th, nearly two months since the inception of vaccine testing, Novavax announced preliminary data from its Phase 1 trial. The vaccine produced a promising immune response in the …
Read MoreBy T. Chakraborty, Ph.D. As COVID-19 continues to affect human lives, global biopharmas have initiated collaborations with research organizations to bring forth innovative drugs against it. Immunic Inc., which focuses …
Read MoreBy Rajaneesh K. Gopinath, Ph.D. BIO Asia-Taiwan 2020 is one of the biggest biotechnology conferences in Asia jointly organized by the Biotechnology Innovation Organization (BIO) and the Taiwan Bio Industry …
Read MoreBy Pavel Ryzhov, Ph.D. With COVID-19 cases escalating around the world, there is an urgent need for a safe and efficacious vaccine. However, the complexity of the R&D process and …
Read MoreBy Sangeeta Chakraborty, Ph.D. Dr. Monica He, Senior Director, International Affairs, BIO moderated the session “Asian opportunities and collaboration” that featured distinguished panelists discussing the collaborative opportunities and business models …
Read MoreBy Sangeeta Chakraborty, Ph.D. & Sahana Shankar, Ph.D. Candidate In the second “combating pandemics” session at BIO Asia-Taiwan, discussions revolved around ways to prepare the world from future pandemics based …
Read MoreBy Sahana Shankar, Ph.D. Candidate At the BIO ASIA-Taiwan conference, Dr. Hong-Jen Chang, President of Taiwan Research-based Pharmaceutical Manufacturers’ Association (TRPMA), moderated a timely showcase on how Taiwan’s government, healthcare …
Read More